Targeted immunotherapy could boost radiotherapy response
E-Mail Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with immunotherapy, a new study suggests. Researchers believe that manipulating bowel cancers based on their 'immune landscape' could unlock new ways to treat resistant tumours. Cancers can evolve resistance to radiotherapy just as they do with drugs. The new study found that profiling the immune landscape of cancers before therapy could identify patients who are likely to respond to radiotherapy off the bat, and others who might benefit from priming of their tumour with immunotherapy. Scientis...